Back to top
more

Aurora Cannabis (ACB)

(Real Time Quote from BATS)

$6.00 USD

6.00
999,246

+0.46 (8.30%)

Updated Nov 4, 2024 12:56 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 30% (74 out of 250)

Industry: Medical - Products

Better trading starts here.

Zacks News

Aurora Cannabis Inc. (ACB) Flat As Market Gains: What You Should Know

In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $4.76, marking no change from the previous day.

Indrajit Bandyopadhyay headshot

Epidolex Progresses: Will the Marijuana Drug Market Boom?

Cannabis (or marijuana) based medical products have the potential to become the next booming industry.

Nilanjan Gupta headshot

Cannabis Industry to Scale New Highs Amid Legalization Woes

Legalization will likely drive commercial distribution of cannabis and boost growth of companies operating in this space.

Aurora Cannabis Inc. (ACB) Flat As Market Gains: What You Should Know

In the latest trading session, Aurora Cannabis Inc. (ACB) closed at $5.27, marking no change from the previous day.

Options Traders Expect Huge Moves in Aurora Cannabis (ACB) Stock

Investors need to pay close attention to Aurora Cannabis (ACB) stock based on the movements in the options market lately.

Aurora Cannabis Inc. (ACB) Reports Break-Even Earnings for Q4

Aurora Cannabis Inc. (ACB) delivered earnings and revenue surprises of 100.00% and 6.30%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?

Benjamin Rains headshot

Bonds, Apple Event, Uber and Lyft Bill & Buy Ciena Stock - Free Lunch

What's next for the Fed and increased corporate bond buying. Apple's (AAPL) highly anticipated event Tuesday. Aurora Cannabis (ACB) earnings. A California bill could shake up Uber (UBER) and Lyft (LYFT). And why Ciena (CIEN) is a Zacks Rank #1 (Strong Buy) stock right now - Free Lunch

Benjamin Rains headshot

Buy Aurora Cannabis (ACB) Stock Before Earnings, Despite Marijuana Volatility?

Despite growing sales and wider legalization, many pot stocks have been insanely volatile as Wall Street and investors try to wrap their heads around the marijuana industry. So should you think about buying "cheap" Aurora Cannabis (ACB) Stock before Q4 earnings?

Aurora Cannabis (ACB) to Report Q4 Earnings: What's in Store?

Cannabis revenue growth and improved gross margin are likely to aid Aurora Cannabis (ACB) in Q4 earnings.

What's in Store for Aurora Cannabis (ACB) in Q4 Earnings?

Aurora Cannabis (ACB) expects revenues within $100-$107 million in fiscal Q4.

Aurora Cannabis Inc. (ACB) Stock Sinks As Market Gains: What You Should Know

Aurora Cannabis Inc. (ACB) closed the most recent trading day at $5.59, moving -1.41% from the previous trading session.

Analysts Estimate Aurora Cannabis Inc. (ACB) to Report a Decline in Earnings: What to Look Out for

Aurora Cannabis Inc. (ACB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Aurora Cannabis Inc. (ACB) Gains But Lags Market: What You Should Know

Aurora Cannabis Inc. (ACB) closed at $5.58 in the latest trading session, marking a +0.18% move from the prior day.

Aurora Cannabis Inc. (ACB) Gains As Market Dips: What You Should Know

Aurora Cannabis Inc. (ACB) closed the most recent trading day at $5.93, moving +1.54% from the previous trading session.

Daniel Laboe headshot

Canopy Growth (CGC) Earnings After The Bell: How High Can They Go?

Canopy is the clear leader in the marijuana space with a vastly diversified portfolio of cannabis products along with its STZ partnership.

HubSpot, Kraft Heinz, CNBS, Canopy Growth, Aurora Cannabis and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day

HubSpot, Kraft Heinz, CNBS, Canopy Growth, Aurora Cannabis and GW Pharmaceuticals highlighted as Zacks Bull and Bear of the Day

Can European Expansion Aid Canopy Growth (CGC) Q1 Earnings?

Canopy Growth's (CGC) recent acquisition of European companies will help it expand its production footprint into one of the most promising international regions.

Tirthankar Chakraborty headshot

Tilray to Report Earnings Today: Will It Top or Flop?

From global marijuana legalization to the rapidly increasing use of CBD as a wellness product, all of this should help Tilray witness an uptick in second-quarter revenues.

Neena Mishra headshot

Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF

CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.

Neena Mishra headshot

Cannabis Expert Tim Seymour's Favorite Pot Stocks and ETF

CNBC's cannabis expert Tim Seymour explains why he launched his own Cannabis ETF.

Panel Of Zacks Experts headshot

Cannabis, Ride Sharing and the never ending trade war, Paper Traders Ep 9

Erique and Danny Talk Through The Trade war impacts and recent earrings reports for Ride Sharing Companies Lyft and Uber.

Sanghamitra Saha headshot

ETFs in Focus as Consolidation Drives Marijuana Industry

Deals activity has been robust in the marijuana space, paving way for gains in these cannabis ETFs.

Factors Setting the Tone for Deere (DE) in Q3 Earnings

Replacement demand for agricultural equipment and strong demand in construction likely to be conducive to Deere's (DE) third-quarter fiscal 2019 results.

Can Cannabis Therapy Drive Canopy Growth's (CGC) Q1 Earnings?

Canopy Growth (CGC) expects to deliver a strong first-quarter fiscal 2020 on solid performance by its cannabis therapy business.

Tilray (TLRY) to Report Q2 Earnings: What's in the Cards?

Investors will focus on revenue growth and other pipeline updates, when Tilray (TLRY) reports second-quarter 2019 results.